Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio-Reference-Cited by-同舟云学术

Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio

Published:2014-08 Issue:4 Volume:7 Page:479-483
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Popovtzer Aron,Normolle Daniel,Worden Francis P.,Prince Mark E.,Chepeha Douglas B.,Wolf Gregory T.,Bradford Carol R.,Lawrence Theodore S.,Eisbruch Avraham

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer;Pignon;Lancet,2000

2. MACH-NC Collaborative Group: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

4. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: a 10-year follow-up;Zorat;J Natl Cancer Inst,2004

5. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer;Vokes;J Clin Oncol,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma;Hereditas;2024-02-27

2. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer;BMC Cancer;2021-07-05

3. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer;2020-08-21

4. Targeting Tumor Metabolism to Overcome Radioresistance;Cancer Drug Discovery and Development;2020

5. Dose-finding designs for trials of molecularly targeted agents and immunotherapies;Journal of Biopharmaceutical Statistics;2017-02-06